Glioblastoma
Glioblastoma is a fast-growing and aggressive type of brain cancer that arises from glial cells, often leading to severe neurological symptoms and a challenging prognosis.
Glioblastoma: [177Lu]Lu-NeoB Treatment Study
We are exploring a new radioactive treatment for patients with newly diagnosed glioblastoma, and testing it alone for those whose cancer has returned. The goal is to find the best dose and understand its effects.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Assistance Publique Hopitaux De Marseille
#1002:Nuclear medicine
Marseille, France
Centre Leon Berard
#1001:Medical Oncology
Meyzieu, France
Centr Georges Francois Leclerc
#1000:Medical Oncology
Saint-Apollinaire, France
Sponsor: Novartis Pharma AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.